Narrow search
Showing 1 - 10 of 91
Cover Image
Promoting vaccinations - an analysis of measures taken by German statutory health insurers
Damm, Kathrin; Schubert, Jana M.; Schulenburg, … - In: Health economics review 1 (2011) 16, pp. 1-6
Introduction: Prophylactic vaccinations play a significant role in health care. As a relatively cost-effective preventive measure they can help to avert transmissible diseases and thus protect not only the vaccinated individuals themselves but also those who have not been vaccinated. In order to...
Persistent link: https://www.econbiz.de/10009503925
Cover Image
The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany
Dintsios, C. M.; Beinhauer, I. - In: Health economics review 10 (2020) 7, pp. 1-25
Background: We analysed the impact of clinical study design for oncological pharmaceuticals on the subsequent price … Health Insurance Funds. The analysis was conducted for all oncology pharmaceuticals that underwent the early benefit …. Further analyses should be performed when more oncology pharmaceuticals have passed the early benefit assessment. …
Persistent link: https://www.econbiz.de/10012291135
Cover Image
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: evidence from an online experiment
Wettstein, Dominik J.; Boes, Stefan - In: Health economics review 10 (2020) 13, pp. 1-15
Background: The necessity to measure and reward "value for money" of new pharmaceuticals has become central in health … study assesses the impact of a negotiation situation for lifeextending pharmaceuticals on societal outcomes. Of interest …
Persistent link: https://www.econbiz.de/10012291180
Cover Image
The effects of drug market regulation on pharmaceutical prices in Europe : overview and evidence from the market of ACE inhibitors
Schulenburg, Fritz von der; Vandoros, Sotiris; Kanavos, … - In: Health economics review 1 (2011) 18, pp. 1-8
in reducing pharmaceuticals prices. Results are not as strong for demand side measures. Profit controls and the use of …
Persistent link: https://www.econbiz.de/10009503923
Cover Image
Impact of educational intervention on willingness-to-pay for health insurance : a study of informal sector workers in urban Bangladesh
Khan, Jahangir A. M.; Ahmed, Sayem - In: Health economics review 3 (2013) 12, pp. 1-10
Background: The reliance on out-of-pocket payments for health services leads to a catastrophic burden for many households in Bangladesh. The World Health Organization suggests that risk-pooling mechanisms should be used for financing healthcare. Like many low-income countries (LIC), a large...
Persistent link: https://www.econbiz.de/10009755995
Cover Image
Utilization of healthcare services and renewal of health insurance membership : evidence of adverse selection in Ghana
Duku, Stephen Kwasi Opoku; Asenso-Boadi, Francis; … - In: Health economics review 6 (2016) 43, pp. 1-12
Background: Utilization of healthcare in Ghana’s novel National Health Insurance Scheme (NHIS) has been increasing since inception with associated high claims bill which threatens the scheme’s financial sustainability. This paper investigates the presence of adverse selection by assessing...
Persistent link: https://www.econbiz.de/10011586649
Cover Image
National health insurance, social influence and antenatal care use in Ghana
Owoo, Nkechi S.; Lambon-Quayefio, Monica P. - In: Health economics review 3 (2013) 19, pp. 1-12
The study explores the importance of social influence and the availability of health insurance on maternal care utilization in Ghana through the use of antenatal care services. A number of studies have found that access to health insurance plays a critical role in women’s decision to utilize...
Persistent link: https://www.econbiz.de/10009783217
Cover Image
Pharmaceutical regulation in Europe and its impact on corporate R&D
Eger, Stephan; Mahlich, Jörg C. - In: Health economics review 4 (2014) 23, pp. 1-9
Objectives: Many European countries regulate the markets for prescription drugs in order to cope with rising health expenditures. On the other hand, regulation distorts incentives to invest in pharmaceutical R&D. This study aims at empirically assessing the impact of regulation on pharmaceutical...
Persistent link: https://www.econbiz.de/10010526909
Cover Image
The impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic medication in Finland
Koskinen, Hanna; Ahola, Elina; Saastamoinen, Leena K.; … - In: Health economics review 4 (2014) 9, pp. 1-10
Objective: To assess the impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic drugs in Finland during the first year after its launch. Furthermore, the additional impact of reference pricing on prior implemented generic substitution is assessed....
Persistent link: https://www.econbiz.de/10010528479
Cover Image
Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
Schobert, Deniz; Remy, Vanessa; Schoeffski, Oliver - In: Health economics review 2 (2012) 19, pp. 1-10
Introduction: Persistent infections with human papillomavirus (HPV) are a necessary cause of cervical cancer and are responsible for important morbidity in men and women. Since 2007, HPV vaccination has been recommended and funded for all girls aged 12 to 17 in Germany. A previously published...
Persistent link: https://www.econbiz.de/10009752876